Home » Supporting Your Practice » Medicine » Pharmacology

Pharmacology

Fentanyl: What you Should Know

Dr. JoonYoung Ji returns on Oasis Discussions to speak about Fentanyl, a potent opioid that has surfaced in recent times as an abused substance responsible for many overdoses and deaths. Dr. Ji explains what Fentanyl is and why it would be found in a dental practice if ever.  We hope you find the conversation valuable and that you share your feedback with us on Oasis Discussions or through oasisdiscussions@cda-adc.ca. Bookmark our page and visit us frequently to keep up to date with the latest in the world of dentistry! Chiraz Guessaier, CDA Oasis Manager Highlights Fentanyl and carfentanyl have recently been in the ...

Read More »

Using Antibiotics Wisely to Combat Rising Drug Resistance

November 13 to 19, 2017 is World Antibiotic Awareness week. I have invited Dr. Shelita Dattani, Director, Practice Development and Knowledge Translation at the Canadian Pharmacists Association, to speak to our audience about antimicrobial resistance and stewardship. The issue is at the forefront of the World Health Organization list of priorities as rising resistance becomes gradually a global phenomenon.  Dr. Dattani spoke about how dentists and pharmacists are playing a crucial role in helping solve this issue.  We hope you find the interview informative and join our conversation. You can always share your feedback with us on Oasis Discussions or through oasisdiscussions@cda-adc.ca. Bookmark our page ...

Read More »

Managing the Pain in Temporomandibular disorders (TMD)

Dr. Aviv Ouanounou returns to Oasis Discussions to highlight valuable information he and his fellow authors, Dr. Goldberg and Dr. Haas, recently published related to the pharmacological management of patients suffering from temporomandibular disorders. He spke with Dr. Suham Alexander, CDA Oasis Clinical Editor.  Submit a question or share your feedback with us through oasisdiscussions@cda-adc.ca  Highlights Temporomandibular disorders (TMD) are prevalent in patients aged 20 – 40 years of age. It is estimated that approximately 30% of population exhibits at least 1 TMD symptom, while approximately 3 – 7% of population have TMD with more severe symptoms. Anxiety, stress and ...

Read More »

Sugar content, cariogenicity, & dental concerns with commonly used medications

It was a pleasure to host my friend Dr. Mark Donaldson to speak about a somewhat ‘less thought-about’ issue for dentists: sugar in commonly prescribed medications for dental patients. We don’t usually think about it much, but much of the medication prescribed today contains quite a bit of sugar, and dental practitioners need to take this fact into consideration when treating their patients, in particular those who are medically compromised.  If you have any questions, Dr. Donaldson would be happy to respond to those. Email us at oasisdiscussions@cda-adc.ca Chiraz Guessaier, CDA Oasis Manger Highlights Oral adverse events such as cariogenicity are often ...

Read More »

Premedication with Antimicrobials: Matching the Right Drug to the Right Bug!

Continuing our series of pharmacological topics, my conversation with Dr. Mark Donaldson was about premedication for dental procedures, in particular, about the management of orofacial infections with antimicrobials. It’s always a pleasure to host Dr. Donaldson on Oasis Discussions, and we hope that you will enjoy as well as benefit from this interview. I also would like to thank Dr. Donaldson for sharing the entire course with our viewers/readers.  Chiraz Guessaier, CDA Oasis Manager Resource Dr. Mark Donaldson: Premedication for Dental Procedures. Course Material. Please note that this material was initially developed for CE purposes. It is, however, presented here as ...

Read More »

Three Drug Classes Every Dental Professional Should Know!

It’s always an honour to meet with Dr. Mark Donaldson, Pharmacologist and senior Executive Director at Vizient Inc. Part of our monthly conversations, Mark spoke about the three drug classes that every dental professional should know: antimicrobials, analgesics, and local anesthetics. I hope you find the interview informative.  Chiraz Guessaier, CDA Oasis Manager Highlights Oral healthcare professionals (OHCPs) are routinely involved with the selection and prescription of medications for their patients. This course is designed to help them become better-informed prescribers of the top three drug classes employed in dentistry: antibiotics, analgesics, and local anesthetics. Patient safety is the number ...

Read More »

CE Showcase ASM2017: Fighting Dental Disease: Drugs, Bugs and Prescription Products

My interview with Dr. Peter Jacobsen went by in a flash! His sense of humor, light-delivery approach, and lively style leaves you glued to the screen, wanting to learn more about the topic presented. Dr. Jacobsen joined me to speak about his upcoming lecture at #ASM150 titled: Fighting Dental Disease: Drugs, Bugs and Prescription Products. Chiraz Guessaier, CDA Oasis Manager Highlights What are the first, second, third drugs of choice for dental infections? Which antifungals have the greatest risk of drug interactions? Are OTC aphthous ulcers medications effective? Can the newest antiviral drugs prevent herpes attacks? Do they put Ginkgo Biloba ...

Read More »

Opioids: The Good, The Bad and The Ugly…

My meetings with Dr. Jose Lança, from the University of Toronto’s Faculty of Dentistry and the Faculty of Medicine, are always so valuable in presenting and delivering extremely useful clinical information that supports every day clinical practice. This interview looks at the opioids crisis that is plaguing North American societies and the role of dentists in it.  Chiraz Guessaier, CDA Oasis Manager Highlights Opioids bind to opioid receptors in the brain. Upon binding to these receptors, opioids have various effects including: Analgesia Sedation/sleepiness Mood changes – dysphoria, euphoria Tolerance/addiction Cough suppression Miosis Endocrine effects Dermatologic effects – itching, sweating GI motility ...

Read More »